Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F01W8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,152
Award facts
- Contract value 100% obligated
- $10,152.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,152.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on December 11, 2025, with an ultimate completion date of December 12, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The company's broad portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. RINVOQ (upadacitinib), a Janus kinase inhibitor used to treat rheumatoid arthritis and other inflammatory conditions, aligns with AmerisourceBergen's extensive experience delivering specialized pharmaceuticals through the DLA Medical Supply Chain to support military health programs worldwide.
Quick answers
Who was awarded contract SPE2DR26F01W8?
SPE2DR26F01W8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26F01W8 worth?
The government has obligated $10,152 on SPE2DR26F01W8.
Is contract SPE2DR26F01W8 an order under another contract?
Yes. SPE2DR26F01W8 is a delivery order under SPE2DR25D2200, an indefinite delivery contract.
Was contract SPE2DR26F01W8 competed?
The extent of competition for SPE2DR26F01W8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award